Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
about
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewAMPA receptor potentiators: from drug design to cognitive enhancementNovel Glutamatergic Treatments for Severe Mood Disorders.Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderNovel glutamatergic drugs for the treatment of mood disorders.Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.NMDA antagonists under investigation for the treatment of major depressive disorder.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Targeting glutamate signalling in depression: progress and prospects.Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.Clinical therapy of hyaluronic acid combined with platelet-rich plasma for the treatment of knee osteoarthritis
P2860
Q26782993-62AC7E5C-27B7-4EA0-A8AA-27709F72D2D5Q35054673-3DADDC60-AA53-451F-BCF0-E150A3CE69E1Q36498659-91A135F8-30A1-49AE-9DD8-B283C1FD6398Q37668014-3C88EC95-0441-4021-A2ED-3A449B567E2DQ38131480-9F9060B8-C17F-47B6-821E-59C136C14141Q38170140-A259C2A1-28AF-4784-9ADC-3438593FC359Q38211107-620926A9-F09C-4A4A-984C-5A390903DB43Q38543238-94278A92-89B6-4AD9-9D3C-9BF9E593119DQ38743867-AED627D5-98A2-4BC0-98E2-64BF736E4B32Q39557334-6127BEE0-83CC-455F-8F10-0DDC03F708D3Q57163653-C8F272C8-D4AB-4D0D-8F69-10DEF3699EE3
P2860
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@ast
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@en
type
label
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@ast
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@en
prefLabel
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@ast
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@en
P2093
P2860
P1433
P1476
Maximum tolerated dose evaluat ...... rt of phase II dose selection.
@en
P2093
Jacques Schipper
Kari R Nations
Larry Ereshefsky
Lev Gertsik
Peter Dogterom
Roberta Bursi
P2860
P304
P356
10.2165/11634360-000000000-00000
P577
2012-09-01T00:00:00Z